指南与共识重症综合管理与镇静镇痛儿科与产科急症

欧洲儿科重症监护病房的体外血液净化治疗:共识声明

Extracorporeal Blood Purification in European Pediatric Intensive Care Units: A Consensus Statement.
指南 / 共识 · JAMA Netw Open · 2025-02-03
一句话结论国际专家小组就儿科重症监护病房体外血液净化治疗达成共识:24个问题中6个获强共识、18个获共识,为床旁决策提供支持。

该共识由15名作者兼儿科重症监护医师组成的专家组采用改良德尔菲法于2022至2024年间制定,基于2020年1月1日至2024年7月15日PubMed和Embase文献检索,调查了8个欧洲国家儿科重症监护病房的体外血液净化治疗应用。共收到116份调查回复,24个问题中6个达成强共识(>90%同意)、18个达成共识(75%-90%同意)。专家组认为连续性肾脏替代治疗标准或增强吸附血滤器及血浆置换是最常应用的体外血液净化治疗。该共识在临床证据有限的领域为儿科重症监护医师的床旁决策提供支持并指导未来研究。

要点

  • 24个问题中6个达成强共识(>90%同意),18个达成共识(75%-90%同意),<49%同意定义为无共识。
  • 专家组认为连续性肾脏替代治疗标准或增强吸附血滤器及血浆置换是最常应用的体外血液净化治疗。
  • 血液吸附证据正在积累但仍有限。
  • 专家小组由15名作者兼儿科重症监护医师组成,来自8个欧洲国家,共收到116份调查回复。

适用人群与场景

  • 欧洲儿科重症监护病房(PICU)中接受体外血液净化治疗(EBPTs)的危重患儿。

诊断标准与关键阈值

  • 共识强度定义:>90%专家同意为强共识;75%-90%同意为共识;<49%同意为无共识。

处置流程与药物剂量

  • 专家组认为连续性肾脏替代治疗标准或增强吸附血滤器及血浆置换是最常应用的体外血液净化治疗。
  • 血液吸附证据正在积累但仍有限。

研究设计与关键结果

  • 采用改良德尔菲法于2022至2024年间制定共识,专家组由15名作者兼儿科重症监护医师组成,来自8个欧洲国家,共收到116份调查回复。
  • 24个问题中6个达成强共识(>90%同意),18个达成共识(75%-90%同意)。
  • 专家组认为连续性肾脏替代治疗标准或增强吸附血滤器及血浆置换是最常应用的体外血液净化治疗,血液吸附证据正在积累但仍有限。

证据类型、等级与局限

  • 证据类型:共识声明(改良德尔菲法),基于2020年1月1日至2024年7月15日PubMed和Embase文献检索。
  • 共识强度:6个问题强共识(>90%同意),18个问题共识(75%-90%同意)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该共识声明可在临床证据有限的领域支持儿科重症监护医师的床旁决策,并指导未来儿科重症监护病房体外血液净化治疗的研究。

指南或共识出处

  • 指南名称:欧洲儿科重症监护病房的体外血液净化治疗:共识声明(Extracorporeal Blood Purification in European Pediatric Intensive Care Units: A Consensus Statement),发表于JAMA Netw Open。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Important advances have been made in extracorporeal blood purification therapies (EBPTs) due to new technologies and biomaterials; however, the lack of established guidelines is a factor in great variability in clinical practice. This aspect is accentuated in pediatric intensive care given the small number of patients with diverse diagnoses treated with EBPT and the technical challenges in treating small children, potentiating the risk of adverse events.

OBJECTIVE: To understand what experienced users of EBPT think about its relevant issues, insight that may have implications for the design of future studies, and the application of EBPTs in patient care.

EVIDENCE REVIEW: Literature search was conducted using the PubMed and Embase databases between January 1, 2020, and July 15, 2024, and a combination of key medical terms. A panel of experts was formed (composed of 15 authors and pediatric intensivists) to develop a consensus statement using a modified Delphi-based model between 2022 and 2024. The panel's core team drafted the initial questionnaire, which explored EBPT use in pediatric intensive care units (PICUs), including clinical indications for initiating and discontinuing use and outcomes for assessing effectiveness and safety. SurveyMonkey was used in the distribution, completion, and revision of the questionnaire, and findings were analyzed. Panelists were asked to rank answer choices. Numerical value for each ranking was translated to a percentage defining the strength of consensus (>90% agreement from panelists signifying strong consensus; <49% signifying no consensus).

FINDINGS: A total of 116 survey responses were received from panelists from 8 European countries. Strong consensus was achieved on 6 of 24 questions and consensus (75%-90% agreement) was reached on 18 of 24 questions. According to the panelists, the continuous renal replacement therapy standard or enhanced adsorption hemofilter and plasma exchange were of interest, representing the most applied EBPTs across various applications. While evidence on hemoadsorption is growing, it remains limited.

CONCLUSIONS AND RELEVANCE: This consensus statement on EBPTs in critically ill pediatric patients was developed by an international panel of experts in areas where clinical evidence is still limited. This consensus statement could support pediatric intensivists in bedside decision-making and guide future research on EBPTs in PICUs.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Bottari G, Buccione E, Bayrakci B, et al. Extracorporeal Blood Purification in European Pediatric Intensive Care Units: A Consensus Statement. JAMA Netw Open. 2025. PMID: 39899300. doi:10.1001/jamanetworkopen.2024.57657

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。